Genoa Ventures

Genoa Ventures Named to Inc.'s Most Founder-Friendly Investors for Fourth Consecutive Year

Genoa Ventures Named to Inc.'s Most Founder-Friendly Investors for Fourth Consecutive Year

Andrea VuturoOctober 29, 2024

Genoa Ventures Elevates Landon Merrill to Partner, Strengthening Leadership in Science-Driven Investing

Genoa Ventures Elevates Landon Merrill to Partner, Strengthening Leadership in Science-Driven Investing

Andrea VuturoOctober 22, 2024

Jenny Rooke Appears on Bloomberg BusinessWeek

Jenny Rooke Appears on Bloomberg BusinessWeek

Andrea VuturoSeptember 12, 2024

Leveraging scientific excellence to improve investment decisions

Leveraging scientific excellence to improve investment decisions

Andrea VuturoJuly 29, 2024

Alida Biosciences Raises $7.5 Million in Series A Funding

Alida Biosciences Raises $7.5 Million in Series A Funding

Andrea VuturoJune 12, 2024

A Conversation with a Nobel Laureate - Dr. Carolyn Bertozzi & Dr. Jenny Rooke

A Conversation with a Nobel Laureate - Dr. Carolyn Bertozzi & Dr. Jenny Rooke

Andrea VuturoJanuary 17, 2024

Genoa Ventures Named to Inc.’s 2023 List of Founder-Friendly Investors for Third Year in a Row

Genoa Ventures Named to Inc.’s 2023 List of Founder-Friendly Investors for Third Year in a Row

Andrea VuturoDecember 1, 2023

Ionpath Launches MIBIplus and MIBIsight, A New Service Offering and User-Friendly Bioinformatics Tools

Ionpath Launches MIBIplus and MIBIsight, A New Service Offering and User-Friendly Bioinformatics Tools

Andrea VuturoNovember 1, 2023

Aqtual Raises $16 Million in Series A Fund

Aqtual Raises $16 Million in Series A Fund

Andrea VuturoNovember 1, 2023

Trends We are Watching in AgriFood Industry in 2023 and Beyond

Trends We are Watching in AgriFood Industry in 2023 and Beyond

Andrea VuturoMay 19, 2023

10 Women Investors Betting Big On Synthetic Biology

10 Women Investors Betting Big On Synthetic Biology

Andrea VuturoMay 10, 2023

How Early-Stage Investors Can Prepare for an Uncertain Outlook

How Early-Stage Investors Can Prepare for an Uncertain Outlook

Jenny Rooke PhD, shares with Fortune how early-stage investors can best prepare for an uncertain future.

Genoa NewsJenny RookeMarch 14, 2023

BrightSpec Announces $18.4 Million Financing Round

BrightSpec Announces $18.4 Million Financing Round

BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by Genoa Ventures and Arboretum Ventures.

Genoa NewsJenny RookeDecember 15, 2022

Genoa Ventures Again Named to Inc.’s Annual List of Founder-Friendly Investors - 2022

Genoa Ventures Again Named to Inc.’s Annual List of Founder-Friendly Investors - 2022

Genoa NewsAndrea VuturoOctober 7, 2022

Jenny Rooke featured in Vator News

Genoa NewsChase WoodwardSeptember 12, 2022

Bond Pet Food raises Series A to "Brew Meat"

Bond Pet Food raises Series A to "Brew Meat"

Genoa NewsChase WoodwardSeptember 12, 2022

Genoa Ventures Closes Second Fund, at $84M

Genoa Ventures Closes Second Fund, at $84M

Genoa NewsAndrea VuturoAugust 3, 2022

Jenny Rooke's Journey is an Inspiration for New Managers

Jenny Rooke's Journey is an Inspiration for New Managers

Genoa NewsAndrea VuturoAugust 3, 2022

Life Sciences Investor Genoa Ventures Raises $84 Million Second Fund

Life Sciences Investor Genoa Ventures Raises $84 Million Second Fund

Genoa NewsAndrea VuturoAugust 3, 2022

VC raises $84M fund to back agbio, foodbio and other non-drug biotechs

VC raises $84M fund to back agbio, foodbio and other non-drug biotechs

Genoa NewsAndrea VuturoAugust 3, 2022